Company Overview of Xetrios Therapeutics, Inc.
Xetrios Therapeutics, Inc. provides research on human therapeutics targeting the TAM RTK family. The company was founded in 2009 and is based in San Diego, California. As of August 7, 2014, Xetrios Therapeutics, Inc. operates as a subsidiary of Kolltan Pharmaceuticals, Inc.
San Diego, CA
Founded in 2009
Key Executives for Xetrios Therapeutics, Inc.
Xetrios Therapeutics, Inc. does not have any Key Executives recorded.
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3Bar Biologics Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|Tax Management Inc||United States|
|NYC2012, Inc.||United States|
|John F. Kennedy Center For The Performing Arts||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Xetrios Therapeutics, Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.